Department of Pharmaceuticals mandates self-declaration for compliance with new Uniform Code for Pharmaceutical Marketing Practices (UCPMP) by 30th June, 2024
The Department of Pharmaceuticals has directed pharmaceutical companies to submit self-declaration... Read More
Stakeholders in medical devices sector urged by CDSCO to ensure timely payment of retention fees to maintain validity of licenses and certificates
The Central Drugs Standard Control Organisation (“CDSCO”) has reiterated that licenses for... Read More
CDSCO allows operational continuity for importers and manufacturers of Class C & D Medical Devices; pending pre-September 2023 licensing applications deemed valid until 16th August, 2024 or CLA decision
The Central Drugs Standard Control Organization (CDSCO) has issued a Circular in response to... Read More